Thalassaemia trials in Poland

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

  Where

  Gdansk, Olsztyn, Opole, Skorzewo, Walbrzych, Warsaw

  Age

  18 years to 64 years

  People

  90 worldwide

  Run by

  Pharmacosmos A/S

  See details and how to joinNCT05693909 · EU 2023-507396-21-00